Overview
Christine Lovly is a Hematologist Oncology specialist and a Hematologist in Nashville, Tennessee. Dr. Lovly is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Lung Adenocarcinoma, and Non-Small Cell Lung Cancer (NSCLC). Dr. Lovly is currently accepting new patients.
Her clinical research consists of co-authoring 135 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Inflammatory Myofibroblastic Tumor.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3601 The Vanderbilt Clinic, Nashville, TN 37232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Lovly isElite. Learn about Lung Cancer.
- Small Cell Lung Cancer (SCLC)
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Lovly isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Lovly isDistinguished. Learn about EGFR Positive Lung Cancer.
- Inflammatory Myofibroblastic TumorDr. Lovly isDistinguished. Learn about Inflammatory Myofibroblastic Tumor.
- Large-Cell Lung CarcinomaDr. Lovly isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Lovly isDistinguished. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Lovly isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Pleuropulmonary BlastomaDr. Lovly isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Mediastinal TumorDr. Lovly isExperienced. Learn about Mediastinal Tumor.
- MelanomaDr. Lovly isExperienced. Learn about Melanoma.
- MesotheliomaDr. Lovly isExperienced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Lovly isExperienced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Lovly isExperienced. Learn about Neuroendocrine Tumor.
- Posterior Fossa TumorDr. Lovly isExperienced. Learn about Posterior Fossa Tumor.